TN2013000515A1 - Notch pathway signaling inhibitor compound - Google Patents
Notch pathway signaling inhibitor compoundInfo
- Publication number
- TN2013000515A1 TN2013000515A1 TNP2013000515A TN2013000515A TN2013000515A1 TN 2013000515 A1 TN2013000515 A1 TN 2013000515A1 TN P2013000515 A TNP2013000515 A TN P2013000515A TN 2013000515 A TN2013000515 A TN 2013000515A TN 2013000515 A1 TN2013000515 A1 TN 2013000515A1
- Authority
- TN
- Tunisia
- Prior art keywords
- signaling inhibitor
- notch pathway
- pathway signaling
- inhibitor compound
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 102000005650 Notch Receptors Human genes 0.000 title abstract 2
- 108010070047 Notch Receptors Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000037361 pathway Effects 0.000 title abstract 2
- 230000011664 signaling Effects 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a compound, or a pharmaceutically acceptable salt or hydrate, and a pharmaceutical composition containing said compound, or a pharmaceutically acceptable salt or hydrate, useful as a Notch pathway signaling inhibitor for the treatment of cancer
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161560486P | 2011-11-16 | 2011-11-16 | |
| PCT/US2012/047100 WO2013016081A1 (en) | 2011-07-27 | 2012-07-18 | Notch pathway signaling inhibitor compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000515A1 true TN2013000515A1 (en) | 2015-03-30 |
Family
ID=54359619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000515A TN2013000515A1 (en) | 2011-11-16 | 2013-12-12 | Notch pathway signaling inhibitor compound |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2013000515A1 (en) |
-
2013
- 2013-12-12 TN TNP2013000515A patent/TN2013000515A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY184303A (en) | Notch pathway signaling inhibitor compound | |
| SA515360469B1 (en) | Heterocyclic compounds for inhibiting glutaminase and their methods of use | |
| IN2014DN10670A (en) | ||
| MX2013011330A (en) | Combinations of akt inhibitor compounds and abiraterone, and methods of use. | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| MX368703B (en) | A benzoic acid derivative mdm2 inhibitor for the treatment of cancer. | |
| MX2011011335A (en) | Inhibitors of pi3 kinase and / or mtor. | |
| MX2011009796A (en) | Inhibitors of pi3 kinase. | |
| MD4659B1 (en) | Polymorph of SYK inhibitors | |
| TN2014000016A1 (en) | 4 - piperidinyl compounds for use as tankyrase inhibitors | |
| MD4684B1 (en) | Imidazopyrazine-based formulations as SYK inhibitors | |
| JO3115B1 (en) | Pyridazinone Compounds and Their Use as DAAO Inhibitors | |
| MX362879B (en) | Novel uses. | |
| MX2015010619A (en) | Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer. | |
| PH12014502492A1 (en) | Pyrazole compounds as sglt1 inhibitors | |
| JO3145B1 (en) | Compounds useful for inhibiting chk1 | |
| TN2013000515A1 (en) | Notch pathway signaling inhibitor compound | |
| UA110834C2 (en) | Compound inhibitor of notch signaling pathway | |
| JOP20120346B1 (en) | Compounds for adhesion treatment and prevention, compound-related pharmaceutical compositions and methods for the prevention and treatment of adhesions | |
| TN2014000077A1 (en) | Pyridazinone compounds and their use as daao inhibitors | |
| TN2011000507A1 (en) | Inhibitors of pi3 kinase and / or mtor |